{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-25-000072","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.095958+00:00","generated_at":"2026-05-19T11:11:21.951327+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Context Therapeutics stockholders approve reverse stock split and ratify auditor at 2025 annual meeting","bullets":["66,716,026 shares (74.37% of outstanding) present at June 12, 2025 annual meeting.","Ratified CohnReznick LLP as auditor for FY2025 with 66,649,293 votes for, 20,039 against.","Approved reverse stock split at ratio from 1:5 to 1:50, as determined by Board; 65,141,783 for, 1,540,542 against.","No broker non-votes reported; both proposals were routine matters."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-25-000072","json":"https://secwatch.observer/filing/0001842952-25-000072.json","markdown":"https://secwatch.observer/filing/0001842952-25-000072.md","text":"https://secwatch.observer/filing/0001842952-25-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295225000072/0001842952-25-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295225000072/cntx-20250612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T11:11:21.951327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}